REPORT HIGHLIGHTS

This report provides:
An overview of global insulin drugs and delivery in pharmaceutical and biotechnology markets with classification and usage in diabetes types, with a focus on insulin pumps.
Analyses of global market trends, with data from 2011 and 2012, estimates for 2013 and 2018 and projections of compound annual growth rates (CAGRs) through 2018.
Evaluation of emerging technologies in the insulin drug and delivery field that have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods.
Patent identifications for insulin as a drug, along with its delivery methods.

STUDY OBJECTIVES

BCC Research’s objective in carrying out this study is to provide an overview of the current and future characteristics of the global market for emerging insulin drugs and delivery technologies. The fundamental objective is to present a comprehensive analysis and identify the future direction of insulin drugs and delivery devices as important tools in treating diabetes with well-tolerated delivery devices.This report explores present and future strategies within the insulin drug and delivery market, which includes syringes, pumps, pens and many newer methods. The market’s improvisation, setbacks and needs are also discussed. The classifications, comparisons and usage of different insulin types and devices are presented as well.A detailed analysis of insulin drugs and delivery industry structure has been conducted. Revenues are broken down by type, as well as by region. Sales figures are estimated for the five-year period from 2013 through 2018.Applications for insulin drugs and delivery are also discussed in a separate section, with emphasis on their usage in treating different types of diabetes. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles. , leading to a steady market for these technologies.Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.Companies’ acquisition strategies and collaborations are covered in this report. This study also discusses the strength and weaknesses of each technology type in light of the new technologies, growing competition and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND FOR WHOM

This study contributes to the areas of market growth for insulin drug and delivery manufacturers and users. It will be of interest to pharmaceutical biotechnical companies, research institutes, hospitals and physicians.

SCOPE OF THE STUDY

The scope of this study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with its classification and its usage in diabetes types. BCC analyzes each market and its applications, as well as its regulatory environment, technology and market share. The markets, such as type 1 diabetes, type 2 diabetes and gestational diabetes, are analyzed for the years 2011 and 2012. The markets are projected through the end of 2013 and for a five-year period until 2018.The market is also segmented by insulin syringes and vials, insulin pens and insulin pumps. Technological issues include the latest trends and developments. The study also includes the patent identifications for insulin as a drug, along with its deliveries.The emerging markets for insulin drug and delivery include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

METHODOLOGY

Both primary and secondary research methodologies were used in the preparation of this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with manufacturers of enzyme inhibitors technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies were surveyed to obtain data for this study. including manufacturers of insulin drugs and delivery technologies and their users in hospitals and medical centers. Data were gathered from various industry sources. BCC Research spoke with officials within the industry and also consulted newsletters; company literature; product literature; and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

Table Of Contents

CHAPTER 1 INTRODUCTION 2
STUDY OBJECTIVES 2
REASONS FOR DOING THIS STUDY 2
CONTRIBUTIONS OF THE STUDY AND FOR WHOM 2
SCOPE OF THE STUDY 3
METHODOLOGY 3
INFORMATION SOURCES 3
ABOUT THE AUTHOR 3
RELATED BCC RESEARCH REPORTS 4
BCC ONLINE SERVICES 4
DISCLAIMER 4
CHAPTER 2 SUMMARY 6
SUMMARY TABLE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
THROUGH 2018 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
2011-2018 ($ MILLIONS) 8
CHAPTER 3 OVERVIEW 10
DIABETES OVERVIEW 10
DIABETES CLASSIFICATION 10
TABLE 1 DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES 11
EPIDEMIOLOGY 13
TABLE 2 ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH
RESPECT TO 2000 13
TYPE 1 DIABETES MELLITUS MANAGEMENT 14
INSULIN 15
HISTORY OF INSULIN ISOLATION AND THE DEVELOPMENT OF ITS ANALOGS 15
TABLE 3 HISTORY OF INSULIN ISOLATION AND DEVELOPMENT 15
STRUCTURE OF INSULIN 16
INSULIN BIOSYNTHESIS 16
INSULIN TYPES 17
TABLE 4 CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS 19
TREATMENT PROTOCOL 20
Multiple Daily Injections 20
TABLE 5 ADVANTAGES AND DISADVANTAGES OF SYRINGES 21
Continuous Subcutaneous Insulin Infusion and Insulin Pump Therapy 21
TABLE 6 INSULIN PUMPS CURRENTLY ON THE MARKET 22
TABLE 7 COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR
VARIOUS INSULIN DELIVERY SYSTEMS 23
TABLE 8 INSULIN PENS CURRENTLY ON THE MARKET 25
ADMINISTRATION ROUTES 26
TABLE 9 INSULIN ADMINISTRATION ROUTES 26
CHAPTER 4 REGULATORY ASPECTS 29
APPROVALS FOR INSULIN DRUGS 29
HLC158A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin
Pumps
TABLE 10 INSULIN DRUG APPROVALS, 2009-MARCH 2013 29
APPROVALS GRANTED FOR INSULIN DEVICES 30
TABLE 11 PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN
DEVICES, 2009-MARCH 2013 30
PREMARKET NOTIFICATION OR 510(K) CLEARANCE 32
TABLE 12 PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN
DEVICES, 2009-MARCH 2013 33
SAFETY ALERTS AND RECALLS 34
TABLE 13 SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013 34
TABLE 14 DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013 35
CHAPTER 5 NEW DEVELOPMENTS 41
NEW TECHNOLOGIES FOR INSULIN DELIVERY 42
INSULIN INHALERS 42
INSULIN SPRAY 42
IMPLANTABLE INSULIN PUMPS 42
TRANSDERMAL PATCH 42
PRODUCT DEVELOPMENT 43
TABLE 15 NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES 43
MERGERS AND ACQUISITIONS 45
TABLE 16 INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND
ACQUISITIONS 46
LICENSING, PARTNERSHIPS, AND AGREEMENTS 47
TABLE 17 LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS
AND DELIVERY DEVICES 48
PIPELINE PRODUCTS 51
TABLE 18 INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS 51
CHAPTER 6 GLOBAL MARKETS 56
MARKET BY TYPE 57
MARKET OVERVIEW 57
MARKET REVENUE 58
TABLE 19 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
THROUGH 2018 ($ MILLIONS) 58
FIGURE 1 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
2011-2018 ($ MILLIONS) 59
MARKET SHARE 59
TABLE 20 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012
(%) 59
FIGURE 2 INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%) 60
MARKET BY REGION 60
MARKET OVERVIEW 61
MARKET REVENUE 62
TABLE 21 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 62
FIGURE 3 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
2011-2018 ($ MILLIONS) 63
MARKET SHARE 63
HLC158A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin
Pumps
TABLE 22 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012
(%) 63
FIGURE 4 INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%) 63
INSULIN SYRINGES AND VIALS 64
Market Overview 64
Market Revenue 64
TABLE 23 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 65
FIGURE 5 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($
MILLIONS) 65
Market Share 65
TABLE 24 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
FIGURE 6 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
INSULIN PENS 66
Market Overview 67
Market Revenue 67
TABLE 25 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 68
FIGURE 7 GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018 ($ MILLIONS) 68
Market Share 68
TABLE 26 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
FIGURE 8 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
INSULIN PUMPS 69
Market Overview 70
Market Revenue 71
TABLE 27 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 71
FIGURE 9 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 72
Market Share 72
TABLE 28 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
FIGURE 10 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
MARKET BY APPLICATIONS 73
TYPE 1 DIABETES 73
TYPE 2 DIABETES 74
GESTATIONAL DIABETES 75
MARKET OVERVIEW 75
MARKET REVENUE 76
TABLE 29 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
THROUGH 2018 ($ MILLIONS) 76
FIGURE 11 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY
APPLICATION, 2011-2018 ($ MILLIONS) 76
MARKET SHARE 77
TABLE 30 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77
FIGURE 12 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY
APPLICATION, 2012 (%) 77
CHAPTER 7 INSULIN PUMP MARKET ANALYSIS 80
MARKET BY TYPE 80
HLC158A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin
Pumps
MARKET OVERVIEW 81
MARKET REVENUE 82
TABLE 31 GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 82
FIGURE 13 GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 83
MARKET SHARE 83
TABLE 32 INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%) 83
FIGURE 14 INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%) 83
MARKET BY REGION 84
MARKET OVERVIEW 84
MARKET REVENUE 85
TABLE 33 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 85
FIGURE 15 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 85
INSULIN PUMPS WITH TUBING 86
Market Overview 86
Market Revenue 87
TABLE 34 GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 88
FIGURE 16 GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 88
TUBELESS INSULIN PUMPS 88
Market Overview 89
Market Revenue 90
TABLE 35 GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, THROUGH 2018
($ MILLIONS) 90
FIGURE 17 GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, 2011-2018 ($
MILLIONS) 90
IMPLANTABLE INSULIN PUMPS 91
Market Overview 91
Market Revenue 93
TABLE 36 GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 93
FIGURE 18 GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 93
MARKET SHARE 94
TABLE 37 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 94
FIGURE 19 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 94
MARKET BY APPLICATIONS 95
TYPE 1 DIABETES 95
TYPE 2 DIABETES 96
GESTATIONAL DIABETES 97
MARKET OVERVIEW 97
MARKET REVENUE 97
TABLE 38 GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 98
FIGURE 20 GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 98
MARKET SHARE 99
HLC158A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin
Pumps
TABLE 39 INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%) 99
FIGURE 21 INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%) 99
INDUSTRY STRUCTURE 99
MARKET LEADERS 100
TABLE 40 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN PUMPS 100
MARKET SHARES 101
TABLE 41 INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%) 101
FIGURE 22 INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%) 101
CHAPTER 8 PATENT ANALYSIS 104
PATENTS BY YEAR 104
TABLE 42 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 104
FIGURE 23 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 104
PATENTS BY TYPE 105
TABLE 43 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 105
FIGURE 24 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 105
PATENTS BY COMPANY 106
TABLE 44 U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013 106
PATENTS BY COUNTRY 108
TABLE 45 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 108
FIGURE 25 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 109
PATENTS BY ASSIGNEE 109
TABLE 46 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 109
FIGURE 26 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 109
CHAPTER 9 CURRENT SITUATION 112
MARKET TRENDS 113
INSULIN PUMPS 113
Artificial Pancreas 113
Closed-Loop Insulin Pump 113
INSULIN PENS 114
INSULIN SYRINGES 114
MODERN INSULIN AND ALTERNATIVE DELIVERY METHODS 114
ORAL INSULIN 114
NASAL INSULIN SPRAY 115
BIOSIMILAR INSULIN 115
OVERALL MARKET DRIVERS FOR INSULIN DELIVERY DEVICE MARKET 115
FACTORS GOVERNING THE INSULIN DELIVERY DEVICE MARKET 116
COLLABORATIONS, MERGERS AND AQUISITIONS 116
CHAPTER 10 COMPANY PROFILES 120
ADOCIA 120
ANIMAS CORPORATION 120
ANTRIABIO 121
BECTON, DICKINSON AND COMPANY 122
BIOCON LIMITED 122
BIODEL INC. 123
HLC158A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin
Pumps
DEBIOTECH 124
ELI LILLY 124
ETERNITY HEALTHCARE 125
F. HOFFMANN-LA ROCHE LTD. (DISETRONIC MEDICAL SYSTEMS AG) 126
GENEREX BIOTECHNOLOGY CORPORATION 126
HALOZYME THERAPEUTICS INC. 127
INSULINE MEDICAL 127
INSULUTION ABM 128
LIFESCAN 128
MANNKIND 129
MARINA BIOTECH INC. 130
MEDTRONIC INC. 131
MICROPORT SCIENTIFIC CORPORATION 131
MIDASOL THERAPEUTICS (JOINT VENTURE OF MIDATECH LTD. AND MONOSOL
RX) 132
NOVO NORDISK 132
ORAMED PHARMACEUTICALS INC. 133
PHOSPHAGENICS LIMITED 134
SANOFI 134
SENSILE MEDICAL AG 135
THERMALIN DIABETES INC. 136
XERIS PHARMACEUTICALS 137
YPSOMED HOLDING AG 137
HLC158A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin
Pumps

LIST OF TABLES

SUMMARY TABLE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
THROUGH 2018 ($ MILLIONS) 7
TABLE 1 DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES 11
TABLE 2 ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH
RESPECT TO 2000 13
TABLE 3 HISTORY OF INSULIN ISOLATION AND DEVELOPMENT 15
TABLE 4 CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS 19
TABLE 5 ADVANTAGES AND DISADVANTAGES OF SYRINGES 21
TABLE 6 INSULIN PUMPS CURRENTLY ON THE MARKET 22
TABLE 7 COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR
VARIOUS INSULIN DELIVERY SYSTEMS 23
TABLE 8 INSULIN PENS CURRENTLY ON THE MARKET 25
TABLE 9 INSULIN ADMINISTRATION ROUTES 26
TABLE 10 INSULIN DRUG APPROVALS, 2009-MARCH 2013 29
TABLE 11 PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN
DEVICES, 2009-MARCH 2013 30
TABLE 12 PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN
DEVICES, 2009-MARCH 2013 33
TABLE 13 SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013 34
TABLE 14 DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009-APRIL 2013 35
TABLE 15 NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES 43
TABLE 16 INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND
ACQUISITIONS 46
TABLE 17 LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS AND
DELIVERY DEVICES 48
TABLE 18 INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS 51
TABLE 19 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
THROUGH 2018 ($ MILLIONS) 58
TABLE 20 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012 (%) 59
TABLE 21 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
THROUGH 2018 ($ MILLIONS) 62
TABLE 22 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012
(%) 63
TABLE 23 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018
($ MILLIONS) 65
TABLE 24 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
TABLE 25 GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 68
TABLE 26 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
TABLE 27 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 71
TABLE 28 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
TABLE 29 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
THROUGH 2018 ($ MILLIONS) 76
TABLE 30 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77
TABLE 31 GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 82
TABLE 32 INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%) 83
TABLE 33 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 85
TABLE 34 GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 88
HLC158A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin
Pumps
TABLE 35 GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($
MILLIONS) 90
TABLE 36 GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 93
TABLE 37 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 94
TABLE 38 GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 98
TABLE 39 INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%) 99
TABLE 40 LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN PUMPS 100
TABLE 41 INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%) 101
TABLE 42 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 104
TABLE 43 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 105
TABLE 44 U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013 106
TABLE 45 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 108
TABLE 46 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 109
HLC158A - Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin
Pumps

LIST OF FIGURES

SUMMARY FIGURE GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET,
2011-2018 ($ MILLIONS) 8
FIGURE 1 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE,
2011-2018 ($ MILLIONS) 59
FIGURE 2 INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012 (%) 60
FIGURE 3 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION,
2011-2018 ($ MILLIONS) 63
FIGURE 4 INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012 (%) 63
FIGURE 5 GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018 ($
MILLIONS) 65
FIGURE 6 INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012 (%) 66
FIGURE 7 GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018 ($ MILLIONS) 68
FIGURE 8 INSULIN PEN MARKET SHARES BY REGION, 2012 (%) 69
FIGURE 9 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 72
FIGURE 10 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 72
FIGURE 11 GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION,
2011-2018 ($ MILLIONS) 76
FIGURE 12 INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION,
2012 (%) 77
FIGURE 13 GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018 ($ MILLIONS) 83
FIGURE 14 INSULIN PUMP MARKET SHARES BY TYPE, 2012 (%) 83
FIGURE 15 GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018 ($ MILLIONS) 85
FIGURE 16 GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 88
FIGURE 17 GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, 2011-2018 ($
MILLIONS) 90
FIGURE 18 GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH
2018 ($ MILLIONS) 93
FIGURE 19 INSULIN PUMP MARKET SHARES BY REGION, 2012 (%) 94
FIGURE 20 GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018 ($
MILLIONS) 98
FIGURE 21 INSULIN PUMP MARKET SHARES BY APPLICATION, 2012 (%) 99
FIGURE 22 INSULIN PUMP MANUFACTURER MARKET SHARES, 2012 (%) 101
FIGURE 23 U.S. PATENTS, JANUARY 2009-MARCH 2013 (%) 104
FIGURE 24 U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013 105
FIGURE 25 U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013 109
FIGURE 26 U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013 109

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Patient Monitoring Devices: Global Markets

Patient Monitoring Devices: Global Markets

  • $ 6 650
  • Industry report
  • April 2014
  • by BCC Research

REPORT HIGHLIGHTS The global patient monitoring device (PMD) market is expected to grow from nearly $14.7 billion in 2013 to reach nearly $21.0 billion in 2018, a compound annual growth rate (CAGR) of ...

Markets for Advanced Wound Management Technologies

Markets for Advanced Wound Management Technologies

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides an overview of advanced wound care products, detailed market analyses and discussions of competitive environments. The study includes information about significant products, ...

Global Condoms Market

Global Condoms Market

  • $ 4 950
  • Industry report
  • May 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Condoms in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Latin America, and Rest of World. ...

Advanced Wound Care Markets

June 2014 $ 4 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.